Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Chinese Patent Office
Moodys
Fuji
AstraZeneca
McKinsey
Chubb
Colorcon
Novartis
Farmers Insurance

Generated: January 21, 2018

DrugPatentWatch Database Preview

Tranexamic acid - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for tranexamic acid and what is the scope of tranexamic acid freedom to operate?

Tranexamic acid
is the generic ingredient in three branded drugs marketed by Pharmacia And Upjohn, Acic Fine Chems, Akorn, Amneal Pharms Co, Aurobindo Pharma Ltd, Emcure Pharms Ltd, Fresenius Kabi Usa, Gland Pharma Ltd, Luitpold, Mylan Institutional, Virtus Pharms, Viva Hlthcare, X-gen Pharms Inc, Zydus Pharms Usa Inc, Ferring Pharms As, Actavis Labs Fl Inc, Amerigen Pharms Ltd, Apotex Inc, and Mylan, and is included in twenty-two NDAs. There are eight patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Tranexamic acid has eight patent family members in two countries.

There are seven drug master file entries for tranexamic acid. Twenty-four suppliers are listed for this compound.
Pharmacology for tranexamic acid
Drug ClassAntifibrinolytic Agent
Physiological EffectDecreased Fibrinolysis
Medical Subject Heading (MeSH) Categories for tranexamic acid

US Patents and Regulatory Information for tranexamic acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms As LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Apotex Inc TRANEXAMIC ACID tranexamic acid TABLET;ORAL 202286-001 Jan 27, 2014 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional TRANEXAMIC ACID tranexamic acid INJECTABLE;INJECTION 091657-001 Nov 3, 2011 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ferring Pharms As LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Fresenius Kabi Usa TRANEXAMIC ACID tranexamic acid INJECTABLE;INJECTION 091596-001 Mar 2, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan TRANEXAMIC ACID tranexamic acid TABLET;ORAL 205133-001 Sep 21, 2015 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CYKLOKAPRON tranexamic acid INJECTABLE;INJECTION 019281-001 Dec 30, 1986 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CYKLOKAPRON tranexamic acid TABLET;ORAL 019280-001 Dec 30, 1986 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Viva Hlthcare TRANEXAMIC ACID tranexamic acid INJECTABLE;INJECTION 206713-001 Jun 27, 2017 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ferring Pharms As LYSTEDA tranexamic acid TABLET;ORAL 022430-001 Nov 13, 2009 AB RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for tranexamic acid

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn CYKLOKAPRON tranexamic acid INJECTABLE;INJECTION 019281-001 Dec 30, 1986 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CYKLOKAPRON tranexamic acid TABLET;ORAL 019280-001 Dec 30, 1986 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for tranexamic acid

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Covington
Chinese Patent Office
Colorcon
UBS
Cipla
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot